A map of deadly infectious diseases known to attack the central nervous system (CNS) of people who are already suffering with ...

HB-500 is a next-generation therapeutic vaccine being developed in collaboration with Gilead Sciences, Inc. (Gilead) as a potential component of ...

Curing HIV will be harder than curing cancer. But new research is promising.HIV is "like a time bomb," said James Riley, a ...

Twenty-seven patients with Chronic Hepatitis B Virus infection (CHB) have now been dosed with VRON-0200 as a single (Prime), or Prime and Boost, intramuscular (i.m.) injection ...

Enhancement of HIV-1 Infectivity. Early work on this topic has ... protein other than CD4 that blocks the function of Env in the virion. Nef enhances infectivity by downregulating this unknown ...

aHKU-Pasteur Research Pole, School of Public Health, The University of Hong Kong, Hong Kong Special Administrative Region, China bWorld Health Organization Collaborating Centre for Infectious Disease ...

What Is an HIV Rash? An HIV rash is irritated skin that affects people who have HIV. It can be itchy, red or purple, or painful. Most people who have HIV get a rash at some point. It’s a common ...

If the immune system is severely damaged by HIV, the person can develop acquired immune deficiency syndrome (AIDS), which can be life-threatening. Approximately 1 million people are infected with ...

A new drug is hugely effective at protecting people from HIV infection and needs to be injected only twice a year. Gilead Sciences, GSK, ViiV Healthcare 1 to 3 years In June 2024, results from a ...